Sort
16,300 grants matching “fatty liver disease”
SRC-2: A Master Metabolic Regulator for Liver-Dependent Intestinal Fat Absorptio
$370,385Bert W O'Malley · Baylor College Of Medicine · P01 · FY2016 · DK
Insulin Resistance, Inflammation and Vascular Remodeling
$370,355Allison B Goldfine · Beth Israel Deaconess Medical Center · P50 · FY2011 · HL
Clinical utility of leptin therapy in syndromic forms of insulin resistance.
$370,211Rebecca Brown · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Molecular and Clinical Studies of Insulin Resistance
$370,211Rebecca Brown · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Sphingolipids in Ethanol-Induced Neuronal Apoptosis
$370,192Mariko Saito · Nathan S. Kline Institute For Psych Res · R01 · FY2009 · AA
Mitochondrial NAD kinase: function and mechanism in metabolism
$370,189Ren Zhang · Wayne State University · R01 · FY2023 · DK
Sibling Assessment in Prevention of Pediatric NAFLD in Hispanic Children
$370,104Miriam B. Vos · Emory University · R01 · FY2022 · NR
Metabolic and Bioenergetic Control in Mitochondrial Diseases
$370,092Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2017 · GM
Metabolic and Bioenergetic Control in Mitochondrial Diseases
$370,092Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2020 · GM
Metabolic and Bioenergetic Control in Mitochondrial Diseases
$370,092Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2019 · GM
Liver fibrosis cell-based assay platform: integrating patient-derived fibrotic liver ECM with primary stellate cells, Kupffer cells, and hepatocytes to accelerate anti-fibrotic drug development
$370,020John David O'Neill · Xylyx Bio, Inc. · R44 · FY2024 · DK
Hepatic Cholesteryl Ester Metabolism and Cholesterol Elimination
$370,013Shobha Ghosh · Virginia Commonwealth University · R01 · FY2012 · HL
Cholesterol Ester Hydrolysis and cholesterol efflux
$370,013Shobha Ghosh · Virginia Commonwealth University · R01 · FY2012 · HL
NPC1L1 and Metabolic Diseases
$370,000Liqing Yu · Wake Forest University Health Sciences · R01 · FY2010 · DK
Dynamic regulation of hepatic SIK1 during fasting and feeding
$370,000Rebecca L Berdeaux · University Of Texas Hlth Sci Ctr Houston · R01 · FY2011 · DK
Endogenous Oxalate Synthesis
$370,000Ross P Holmes · Wake Forest University Health Sciences · R01 · FY2011 · DK
Macrophage, ABCA1, Inflammation, and Atherosclerosis
$370,000John S Parks · Wake Forest University Health Sciences · R01 · FY2011 · HL
Inflammation, Atherosclerosis and ApoA-I
$370,000Mary G Sorci-Thomas · Wake Forest University Health Sciences · R01 · FY2011 · HL
Non-Coding Variants of Angiotensinogen Gene and Hypertension
$370,000Ashok Kumar Kumar · New York Medical College · R01 · FY2016 · HL
Role of Retroelements in Environmental Atherogenesis
$370,000Kenneth S Ramos · University Of Louisville · R01 · FY2009 · ES
Effects of A1AT on PCSK9 expression and function
$370,000Dayami Lopez · North Carolina Central University · SC1 · FY2021 · GM
Effects of A1AT on PCSK9 expression and function
$370,000Dayami Lopez · North Carolina Central University · SC1 · FY2019 · GM
Non-platelet P2Y Receptor in Vascular Inflammation and Thrombogenesis
$370,000Jianzhong Shen · Auburn University At Auburn · R01 · FY2020 · HL
Role of Retroelements in Environmental Atherogenesis
$370,000Yong Li · University Of Louisville · R01 · FY2010 · ES
Macrophage AMPK, Inflammation, and Atherosclerosis
$370,000Bingzhong Xue · Georgia State University · R01 · FY2016 · HL